Michael J. Barnett

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy

Carolyn Owen, Cynthia L. Toze, Anna Koochin et al. · Blood · 2008 · 240 citations · Full text

Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

Tim H. Brümmendorf, Tessa L. Holyoake, Nathalie Rufer et al. · Blood · 2000 · 205 citations

Small Noncleaved, Non-Burkitt's (Burkitt-Like) Lymphoma: Cytogenetics Predict Outcome and Reflect Clinical Presentation

Nicol Macpherson, David Lesack, Richard Klasa et al. · Journal of Clinical Oncology · 1999 · 184 citations

Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

Philip B. McGlave, Paolo de Fabritiis, A. B. Deisseroth et al. · The Lancet · 1994 · 176 citations

Hematological Malignancy, Autologous Transplants, Transplantation +9

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease.

Donna Reece, Michael J. Barnett, J M Connors et al. · Journal of Clinical Oncology · 1991 · 176 citations

Immunology, Cell Replacement Therapy, Pharmacotherapy +20